跳至主要内容
临床试验/ACTRN12612000759897
ACTRN12612000759897已完成2 期

A pilot study of the feasibility of performing Focal Ablative Stereotactic Radiosurgery for Cancers of the Kidney or Isolated Adrenal Metastases.

Dr Shankar Siva0 个研究点目标入组 30 人开始时间: 2012年7月17日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Age > 18 years old
  • -All patients must have radiological diagnosis or biopsy confirmed diagnosis of either:
  • (a) Cohort 1: renal cell carcinoma with a single lesion within kidney, or with primary kidney tumour intact and no more than 5 documented metastases, or
  • (b) Cohort 2: solitary adrenal metastases with with primary disease controlled
  • -ECOG performance of 0-2 inclusive.
  • -Either medically inoperable, technically high risk for surgery or decline surgery.
  • -Informed consent.

排除标准

  • -Cytotoxic chemotherapy within 3 weeks of commencement of treatment, or concurrently with treatment. Targeted agents (such as sunitinib) are allowable.
  • -Any patient who is currently pregnant or breastfeeding.
  • -Previous high-dose radiotherapy to upper abdomen

研究者

发起方
Dr Shankar Siva

相似试验